Windtree Therapeutics Inc (NASDAQ: WINT) Has Decreased By -95.59 Percent This Year. Is It A Better Buy Than Others?
Windtree Therapeutics Inc (NASDAQ:WINT)’s traded shares stood at 78.17 million during the last session, with the company’s beta value hitting 0.58. At the close of